Despite the fact that more than a third of U.S. adults are obese, it's been an uphill battle for developers of obesity treatments.» Read More
A combination of Vertex drugs met the goals of two late-stage clinical trials in cystic fibrosis, setting the stage for Vertex to apply for approval.
A U.S. Senate panel asked the Centers for Disease Control and Prevention to explain the breach that exposed many to live anthrax, a deadly pathogen.
A government agency is claiming that the VA's own investigation of itself holds contradictions, CNBC has learned.
Vertex's Kalydeco was the first medicine to address the underlying genetic cause. A new drug combination, Kalydeco and Lumacaftor, is designed to treat many additional cases.
Allergan advised investors not to sell their shares to Valeant, which launched a hostile takeover offer for the Botox maker last week.
Expanding Medicaid eligibility will significantly affect uninsured rates in seven major cities, and bring them billions in federal money, according to a study.
Researchers have discovered that an FDA-approved arthritis drug may hold the secret to curing hairlessness.
Genetics startup 23andMe said it is one step closer to resuming sales of its full-fledged health product.
Wealthy Americans worry about the impact of high health care costs in old age, and see it as one of the biggest risks to their financial security.
People who had their old health care plans canceled aren't necessarily paying higher premiums under Obamacare, according to a Kaiser Family Foundation survey.
Prosecutors have issued subpoenas in an investigation into whether congressional staff tipped stock traders to a change in health-care policy. The WSJ reports.
Senators criticized Dr. Mehmet Oz during a hearing on false diet-product ads on Tuesday, but does he control the "Dr. Oz Effect?"
People who receive subsidies and opted for the second-cheapest group HealthCare.gov plans now pay just $69 per month on average in premiums.
ZocDoc is the new king of New York start-ups.
Mehmet Oz acknowledged that his backing of so called miracle weight loss products has caused trouble to for the FTC, Consumerist reports.
Electronic cigarettes, promoted as a healthier alternative to tobacco, are getting powerful new backers: big tobacco firms. NYT reports.
Valeant said it plans to launch an exchange offer to Allergan shareholders this week, soliciting proxies to call for a meeting to discuss its offer.
The Food and Drug Administration is preparing voluntary guidelines for the food industry to lower sodium levels to address health concerns.
As the global population ages, some see investment opportunities in somewhat ghoulish bets the rates of cancer and other illnesses will rise.
The United States health-care system has again come in last in a comparison of other first-world countries, despite vastly outspending those nations.
Get the best of CNBC in your inbox